Amneal Pharmaceuticals, Inc. (AMRX)

Amneal Pharmaceuticals Revenue

Amneal Pharmaceuticals had revenue of $722.52M in the quarter ending March 31, 2026, with 3.90% growth. This brings the company's revenue in the last twelve months to $3.05B, up 7.62% year-over-year. In the year 2025, Amneal Pharmaceuticals had annual revenue of $3.02B with 8.05% growth.

• Revenue (ttm): $3.05B
• Revenue Growth: +7.62%
• P/S Ratio: 1.32
• Revenue / Employee: $350,099
• Employees: 8,700
• Market Cap: 3.99B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	3.02B	224.80M	8.05%
Dec 31, 2024	2.79B	400.35M	16.73%
Dec 31, 2023	2.39B	181.31M	8.20%
Dec 31, 2022	2.21B	118.63M	5.67%
Dec 31, 2021	2.09B	101.15M	5.08%
Dec 31, 2020	1.99B	366.15M	22.51%
Dec 31, 2019	1.63B	-36.62M	-2.20%
Dec 31, 2018	1.66B	629.34M	60.89%
Dec 31, 2017	1.03B	15.42M	1.51%
Dec 31, 2016	1.02B	151.95M	17.54%
Dec 31, 2015	866.28M	-	-

Data Source: Fiscal.ai Last updated: May 7, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 13, 2026

Data Sources Report a data error